Roche glucose monitors removed from NY Medicaid program

The state of New York's Medicaid system has booted Roche Diagnostics' glucose strips and monitors from its preferred manufacturer list, Mass Device reports, and this move could cost the company millions of customers. In its latest issue of the New York State Medicaid Update, regulators modified the state's diabetic supply program to include only three manufacturers, Abbott Laboratories, Bayer and LifeScan, a subsidiary of Johnson & Johnson. Glucose strips and monitors made by Roche were taken off the list effective March 1. Story  

Suggested Articles

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.